Cash And Equivalent Cambiamento Data
AbbVie USD 13.29B 4.53B 2023-09
Acadia Pharmaceuticals USD 188.66M 90.46M 2023-12
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
Amgen USD 10.94B 23.8B 2023-12
Astellas Pharma JPY 333.99B 227.49B 2023-09
Bayer EUR 6.82B 2.33B 2023-09
Biogen USD 1.05B 1.24B 2023-12
BioMarin Pharmaceutical USD 755.13M 30.29M 2023-12
Bluebird Bio USD 165.35M 7.52M 2023-09
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Celldex Therapeutics USD 34.81M 13.68M 2023-12
Daiichi Sankyo JPY 590.77B 71.1B 2023-09
Eisai JPY 281.45B 12.15B 2023-09
Eli Lilly USD 2.38B 313.7M 2023-09
Esperion Therapeutics USD 114.83M 23.64M 2023-09
Exelixis USD 396.86M 67.62M 2023-09
Genmab DKK 14.27B 3.4B 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
Incyte USD 3.21B 13.85M 2023-12
Insmed USD 482.37M 4.74M 2023-12
Merck USD 8.6B 2.94B 2023-09
Moderna USD 2.91B 25M 2023-12
Nektar Therapeutics USD 64.92M 14.19M 2023-09
Pfizer USD 3.15B 516M 2023-09
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Sarepta Therapeutics USD 541.93M 310M 2023-09
Takeda JPY 318.05B 1.67B 2023-09
Teva Pharmaceutical Industries USD 2.25B 420M 2023-09
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09
Xencor USD 53.79M 1.06M 2023-12



Seattle Genetics Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.